News
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...
Lucknow: King George's Medical University (KGMU) claims to be the first govt institute in Uttar Pradesh to successfully ...
4d
inews.co.uk on MSNThe incurable lung disease costing NHS £40m a year – but you've never heard of itBronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...
Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...
The patient, diagnosed with PAP, was admitted to hospital with breathlessness, dry cough and high oxygen requirement of ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
Coreline Soft, a leading provider of AI-based medical imaging solutions, announced it will co-host a strategic webinar with ...
HeartLung.AI, a leader in AI-powered medical imaging solutions for cardiovascular health and preventive cardiology, will ...
Vivian Health reports AI is revolutionizing medical imaging, enhancing speed, accuracy, and patient care through advanced ...
Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest number of deaths because it is often ...
In this randomized controlled trial, treatment with nerandomilast led to slower declines in forced vital capacity (FVC) in patients with progressive pulmonary fibrosis over 52 weeks 2. The occurrence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results